Article
Carbonic anhydrase IX in renal cell carcinoma: implications for prognosis, diagnosis, and therapy.
European urology - 1 Jul 2010
Stillebroer Alexander B, Mulders Peter F A, Boerman Otto C, Oyen Wim J G, Oosterwijk Egbert
Abstract excerpt
CONTEXT: The clinical management of patients with renal cell carcinoma (RCC) remains difficult, and the development of new diagnostic, prognostic, and therapeutic tools is still required. OBJECTIVE: To review the current knowledge on the RCC-associated antigen carbonic anhydrase IX (CAIX) and provide evidence for how this antigen may aid in the clinical management of RCC. EVIDENCE ACQUISITION: Clinical papers...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
